Zacks Investment Research lowered shares of Nuvectra (NASDAQ:NVTR) from a buy rating to a hold rating in a report issued on Wednesday morning.
According to Zacks, “Nuvectra Corporation develops and commercializes neuromodulation medical device for the treatment of nervous system disorders. It also provides neural interface technology, components and systems, as well as NeuroNexus SmartBox portable control and data streaming systems. Nuvectra Corporation is based in Plano, Texas. “
Get Nuvectra alerts:Other analysts also recently issued research reports about the company. BidaskClub raised Nuvectra from a hold rating to a buy rating in a research note on Saturday, August 18th. JMP Securities lifted their price target on Nuvectra from $18.00 to $23.00 and gave the company a market outperform rating in a research note on Wednesday, August 8th. Piper Jaffray Companies reissued a buy rating and issued a $21.00 price target on shares of Nuvectra in a research note on Wednesday, August 8th. SunTrust Banks lifted their price target on Nuvectra to $27.00 and gave the company a buy rating in a research note on Thursday, June 21st. Finally, ValuEngine raised Nuvectra from a hold rating to a buy rating in a research note on Saturday, June 2nd. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The company presently has an average rating of Buy and a consensus target price of $23.50.
Top 5 Medical Stocks To Buy For 2019: Marten Transport, Ltd.(MRTN)
Advisors' Opinion:- [By Joseph Griffin]
TRADEMARK VIOLATION NOTICE: “Marten Transport, Ltd (MRTN) Chairman Randolph L. Marten Sells 9,997 Shares” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/4147970/marten-transport-ltd-mrtn-chairman-randolph-l-marten-sells-9997-shares.html.
- [By Stephan Byrd]
Victory Capital Management Inc. lifted its stake in Marten Transport, Ltd (NASDAQ:MRTN) by 19.3% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 21,089 shares of the transportation company’s stock after buying an additional 3,410 shares during the quarter. Victory Capital Management Inc.’s holdings in Marten Transport were worth $481,000 at the end of the most recent reporting period.
- [By Stephan Byrd]
Strs Ohio lifted its holdings in shares of Marten Transport, Ltd (NASDAQ:MRTN) by 9.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,800 shares of the transportation company’s stock after acquiring an additional 3,200 shares during the quarter. Strs Ohio’s holdings in Marten Transport were worth $839,000 as of its most recent filing with the Securities and Exchange Commission.
Top 5 Medical Stocks To Buy For 2019: NovoCure Limited(NVCR)
Advisors' Opinion:- [By Shane Hupp]
Novocure Ltd (NASDAQ:NVCR) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $45.45 and last traded at $45.05, with a volume of 834974 shares trading hands. The stock had previously closed at $43.30.
- [By Beth McKenna]
Novocure Ltd. (NASDAQ:NVCR) stock jumped 16.3% in September, according to data from S&P Global Market Intelligence. For context, the S&P 500 returned 0.6% last month.
- [By Stephan Byrd]
JPMorgan Chase & Co. reaffirmed their buy rating on shares of Novocure (NASDAQ:NVCR) in a report issued on Sunday morning.
NVCR has been the subject of a number of other research reports. Mizuho reaffirmed a buy rating and issued a $32.00 price objective on shares of Novocure in a report on Wednesday, June 13th. BidaskClub downgraded shares of Novocure from a strong-buy rating to a buy rating in a report on Tuesday, July 31st. Evercore ISI began coverage on shares of Novocure in a report on Monday, July 16th. They issued an outperform rating and a $46.00 price objective for the company. Wedbush lifted their price objective on shares of Novocure from $33.00 to $40.00 and gave the stock an outperform rating in a report on Friday, July 27th. Finally, Deutsche Bank downgraded shares of Novocure from a buy rating to a hold rating in a report on Wednesday, July 25th. They noted that the move was a valuation call. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Novocure currently has an average rating of Buy and an average target price of $40.29.
- [By Joseph Griffin]
Schwab Charles Investment Management Inc. increased its position in Novocure Ltd (NASDAQ:NVCR) by 30.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 133,900 shares of the medical equipment provider’s stock after buying an additional 31,300 shares during the quarter. Schwab Charles Investment Management Inc. owned about 0.14% of Novocure worth $4,192,000 as of its most recent filing with the Securities and Exchange Commission.
Top 5 Medical Stocks To Buy For 2019: SemiLEDS Corporation(LEDS)
Advisors' Opinion:- [By Lisa Levin] Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares rose 35.8 percent to $4.55. EVINE Live Inc. (NASDAQ: EVLV) gained 28.8 percent to $1.04. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet. Sanmina Corp (NASDAQ: SANM) shares surged 19.1 percent to $33.00 as the company reported stronger-than-expected earnings for its second quarter on Monday. Heidrick & Struggles International, Inc. (NASDAQ: HSII) gained 14.9 percent to $37.22 as the company posted upbeat results for its first quarter. Santander Consumer USA Holdings Inc. (NYSE: SC) shares climbed 14 percent to $17.90 following upbeat quarterly earnings. Helix Energy Solutions Group, Inc. (NYSE: HLX) climbed 14 percent to $7.12 following strong quarterly results. Check-Cap Ltd. (NASDAQ: CHEK) gained 13.6 percent to $8.25. Atossa Genetics Inc. (NASDAQ: ATOS) rose 11.8 percent to $3.34. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men. Cadence Design Systems, Inc. (NASDAQ: CDNS) gained 11.6 percent to $40.99 after the company posted upbeat Q1 results and issued a strong Q2 forecast. Genprex, Inc. (NASDAQ: GNPX) climbed 11.2 percent to $4.9363. Mitel Networks Corporation (NASDAQ: MITL) rose 10.5 percent to $11.23 after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion. Systemax Inc. (NYSE: SYX) rose 10.2 percent to $30.86. Sidoti & Co. upgraded Systemax from Neutral to Buy. Orchids Paper Products Company (NYSE: TIS) surged 9.2 percent to $7.13. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018. New Oriental Education & Technology Group Inc. (NYSE: EDU) rose
- [By Logan Wallace]
QuickLogic (NASDAQ: QUIK) and SemiLEDs (NASDAQ:LEDS) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, dividends, analyst recommendations and profitability.
- [By Lisa Levin] Gainers Check-Cap Ltd. (NASDAQ: CHEK) shares jumped 104.82 percent to close at $14.87 on Tuesday. EVINE Live Inc. (NASDAQ: EVLV) rose 31.25 percent to close at $1.06. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet. SemiLEDs Corporation (NASDAQ: LEDS) shares climbed 27.16 percent to close at $4.26 on Tuesday. Atossa Genetics Inc. (NASDAQ: ATOS) gained 27.09 percent to close at $3.80. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men. Heidrick & Struggles International, Inc. (NASDAQ: HSII) surged 17.13 percent to close at $37.95 as the company posted upbeat results for its first quarter. Santander Consumer USA Holdings Inc. (NYSE: SC) shares gained 15.91 percent to close at $18.21 following upbeat quarterly earnings. Riot Blockchain, Inc. (NASDAQ: RIOT) shares jumped 15.73 percent to close at $7.58 on Tuesday after declining 1.50 percent on Monday. Sanmina Corp (NASDAQ: SANM) shares gained 14.62 percent to close at $31.75 as the company reported stronger-than-expected earnings for its second quarter on Monday. Orchids Paper Products Company (NYSE: TIS) jumped 12.86 percent to close at $7.37. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018. Helix Energy Solutions Group, Inc. (NYSE: HLX) rose 12.8 percent to close at $7.05 following strong quarterly results. Avid Bioservices, Inc. (NASDAQ: CDMO) rose 12.72 percent to close at $3.81. Genprex, Inc. (NASDAQ: GNPX) gained 12.61 percent to close at $5.00. Obalon Therapeutics, Inc. (NASDAQ: OBLN) rose 12.39 percent to close at $3.72. NextDecade Corporation (NASDAQ: NEXT) shares climbed 11.88 percent to close at $7
Top 5 Medical Stocks To Buy For 2019: First Busey Corporation(BUSE)
Advisors' Opinion:- [By Shane Hupp]
Get a free copy of the Zacks research report on First Busey (BUSE)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Get a free copy of the Zacks research report on First Busey (BUSE)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp bought a new stake in shares of First Busey Co. (NASDAQ:BUSE) during the 1st quarter, Holdings Channel reports. The firm bought 7,000 shares of the bank’s stock, valued at approximately $208,000.
Top 5 Medical Stocks To Buy For 2019: Paylocity Holding Corporation(PCTY)
Advisors' Opinion:- [By Ethan Ryder]
Paylocity (NASDAQ:PCTY) and Workiva (NYSE:WK) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, profitability, valuation and earnings.
- [By Ethan Ryder]
ILLEGAL ACTIVITY WARNING: “Paylocity Holding Corp (PCTY) Shares Bought by OLD National Bancorp IN” was published by Ticker Report and is owned by of Ticker Report. If you are viewing this piece on another website, it was copied illegally and republished in violation of United States and international trademark & copyright law. The original version of this piece can be accessed at https://www.tickerreport.com/banking-finance/4141322/paylocity-holding-corp-pcty-shares-bought-by-old-national-bancorp-in.html.
- [By Motley Fool Transcribers]
Paylocity Holding Corp (NASDAQ:PCTY)Q2 2019 Earnings Conference CallFeb. 06, 2019, 5:00 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Paylocity (PCTY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Guggenheim initiated coverage on shares of Paylocity (NASDAQ:PCTY) in a research report released on Monday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $80.00 price target on the software maker’s stock.
No comments:
Post a Comment